Applicant, as named in the Orange Book

Merz

Next listed expiry: Inbrija on 21 Oct 2033. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Inbrija levodopa	levodopa	209184	21 Oct 2033	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ampyra dalfampridine	dalfampridine	022250	open now	no listed protection